Clinical Trial

The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The evidence on the practice of remimazolam besylate during cardiac anesthesia is scarce. This study investigates the efficacy and safety of remimazolam besylate general induction and maintenance during cardiac surgery.
Trial Details
NCT Number NCT06717945
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Anesthesia
Enrollment 320 participants
Start Date 2025-01
Primary Completion 2025-05 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-12-05